Overview

Veterinary Vaccines Market is poised to register a CAGR of 7.2% during the forecast period 2022 to 2028.

Veterinary vaccinations are parenteral medications used to halt infectious illnesses brought on by various causative Agents. These vaccinations protect animals against numerous illnesses that can be fatal. The longevity, health, and overall production of livestock and pets can all be effectively increased with the help of veterinary vaccines. Live-attenuated, inactivated, recombinant, toxoid, and other types of vaccines are included in the classification of veterinary vaccines. Vaccinating companion animals, poultry, swine, ruminants, and aquaculture is a major usage for these products. The most widely used veterinary vaccinations include those for rabies, equine influenza virus, and foot-and-mouth disease. These vaccines prevent the spread of infectious diseases by simulating naturally developed immunity. The Veterinary Vaccines Market is expected to expand steadily due to rising pet ownership in developed countries and an increase in the number of livestock and poultry in emerging nations. The Veterinary Vaccines Market is expected to rise as a result of the surge in vaccine R&D funding, which prevents the development of antibiotic-resistant pathogens. A number of new vaccinations have also been developed as a result of the rising need for animal vaccines. Additionally, the spread of zoonotic and animal illnesses as well as the ongoing development of technologically improved vaccines have changed the dynamics of the market. The market has seen a shift in trend from live attenuated vaccines to DNA vaccines, and recombinant vaccination solutions are being quickly adopted. These elements are expected to favourably fuel the global market for veterinary vaccines. The growth of the market will be restricted by a number of limitations and obstacles.

This market is one of the lucrative alternatives of investments seeking attention and investments from both non-government and government key players. The shifting emphasis on healthy animal husbandry and an increasing number of pet owners are other important factors boosting the market proliferation. The intervention of the government in channel distribution whereas, it is affecting the overall profits incurred by the manufacturers of the veterinary vaccines.

Attenuated vaccines segment dominated the market owing to advantages, for instance, enhanced long-term prevention and improved effectivity. Cattle vaccinations held the largest global veterinary vaccines market share owing to the rise in the insistence for safe and effective animal products. The companion animal vaccines are currently proliferating due to an increase in the number of pet ownerships across the world. The North American region subjugated the market in 2018. Rising animal product commercialization and increasing awareness regarding the health of animals are prime reasons for the region’s domination over the forecast period. The Asia Pacific region is predicted to exhibit rapid augmentation during the forecast timeframe due to faster adoption of animal vaccines for better animal health and high-quality food products.

Key market players included in the global veterinary vaccines industry are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac,Vetoquinol, Phibro Animal Health, Hester Biosciences, HIPRA, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-technology, Endovac Animal Health, Brilliant Bio Pharma Private Limited, Aptimmune Biologics, Indian Immunologicals Ltd., Torigen, VEROVACCiNES.

Global Veterinary Vaccines Market Segmentation:

By Type

• Porcine Vaccines
• Poultry Vaccines
• Livestock Vaccines
o Bovine Vaccines
o Small Ruminant Vaccines
• Companion Animal Vaccines
o Canine Vaccines
o Feline Vaccines
• Aquaculture Vaccines
• Other Animal Vaccines

By Disease

• Porcine
• Poultry
• Livestock
  o Bovine
  o Small Ruminants
• Companion Animals
  o Canine
  o Feline
• Aquaculture

By Technology

Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other Vaccines

By Region

Europe
North America
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global veterinary vaccines market by type, by disease, by technology and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com